2 studies found for:    11990853 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Withdrawn A Pilot, Open-label Study of 18F-Fluciclatide PET/CT Imaging in the Evaluation of Anti-angiogenic Therapy in Solid Tumors
Conditions: Colon Cancer;   Lung Cancer;   Cervical Cancer;   Renal Cell Carcinoma;   Uterine Cancer
Intervention: Drug: (18)Fluciclatide
2 Withdrawn [18]F-Fluciclatide for Kidney Cancer Imaging Studies and Treatment
Condition: Kidney Neoplasms
Intervention: Drug: 18F-Fluciclatide

Indicates status has not been verified in more than two years